Iterum stock slumps 40% after FDA identifies deficiencies in sulopenem NDA
July 02 2021 - 2:27AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Iterum Therapeutics (NASDAQ:ITRM)
Historical Stock Chart
From Apr 2023 to Apr 2024